De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study
De-Ritis-Ratio und Heparintherapie bei sepsisassoziierter Leberschädigung: multizentrische Kohortenstudie
Thrombosis and Haemostasis · 23.04.2026
DOI: 10.1055/a-2852-9288 ↗Auf einen Blick
Bei 9.561 Patient:innen mit sepsisassoziierter Leberschädigung war UFH mit geringerer ICU-Mortalität assoziiert. Ein signifikanter Interaktionseffekt zwischen De-Ritis-Ratio und UFH zeigte sich nicht.
Fragestellung
Identifiziert die De-Ritis-Ratio bei SALI ein Subphänotyp, der unterschiedlich von UFH profitiert?
Methode
Retrospektive multizentrische Kohortenstudie; Analyse mit PSM und MSCM in MIMIC-IV und eICU-CRD.
Ergebnisse
UFH war nach PSM mit geringerer ICU-Mortalität assoziiert: MIMIC-IV HR 0,34 (95 %-KI 0,28–0,42), eICU HR 0,43 (95 %-KI 0,29–0,65). In MSCM ebenfalls reduziert: HR 0,22 (95 %-KI 0,17–0,30).
Einschränkungen
Keine signifikante Interaktion zwischen UFH und De-Ritis-Ratio in beiden Kohorten.
Schlussfolgerung der Autor:innen
UFH war mit reduzierter Mortalität bei SALI assoziiert. Die De-Ritis-Ratio ist zwar ein Risikomarker, aber kein prädiktiver Biomarker für das UFH-Ansprechen.
Kernaussagen
- UFH war mit niedrigerer ICU-Mortalität assoziiert.
- Kein signifikanter UFH×DRR-Interaktionseffekt.
- Prospektive randomisierte Prüfung wird von den Autor:innen gefordert.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Kohortenstudie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 23.04.2026. Verfasst von Bo Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota, United States. Gefördert von: Sanming Project of Medicine in Shenzhen, Sanming Project of Medicine in Shenzhen, Guangming.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis-associated liver injury (SALI) is a highly heterogeneous thromboinflammatory disorder with no specific treatment. The De Ritis ratio (DRR, aspartate aminotransferase/alanine aminotransferase) stratifies mortality risk, and unfractionated heparin (UFH) possesses pleiotropic effects that may attenuate thromboinflammation. We investigated whether DRR identifies a SALI subphenotype that derives differential benefit from UFH therapy.
Methods
This retrospective multicenter cohort study included 9,561 SALI patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV; n = 6,133) and eICU-CRD (n = 3,428) databases. The primary outcome was intensive care unit (ICU) mortality. We employed propensity score matching (PSM) and marginal structural Cox models (MSCM) to adjust for baseline and time-varying confounders. Subgroup analyses evaluated the association between UFH and mortality across DRR strata, with formal testing for UFH × DRR interaction.
Results
UFH therapy was associated with significantly reduced ICU mortality after PSM in both cohorts MIMIC-IV (hazard ratio [HR]: 0.34, 95% confidence interval [CI]: 0.28–0.42) and eICU (HR: 0.43, 95% CI: 0.29–0.65), with consistent results in MSCM analyses (HR: 0.22, 95% CI: 0.17–0.30). Subgroup analysis suggested numerical benefit in patients with DRR > 1, but formal tests for interaction were not significant in either cohort (MIMIC-IV: p = 0.111; eICU: p = 0.775).
Conclusion
UFH therapy is associated with reduced mortality in SALI patients. Although DRR identifies a high-risk subgroup, the lack of significant interaction precludes its use as a predictive biomarker for UFH response. A prospective randomized trial is warranted to validate these findings and DRR-stratified UFH benefits.
Autor:innen und Institutionen
- Department of Medicine, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota, United States.
- Department of Infection and Critical Care Medicine, Shenzhen Second People's Hospital & First Affiliated Hospital of Shenzhen University, Shenzhen, China.
- Department of Critical Care Medicine, Shenzhen University of Advanced Technology General Hospital, Shenzhen, China.
- Department of Central Laboratory, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
- Department of Hospital-Acquired Infection Control, Shenzhen Second People's Hospital, Shenzhen, China.
- Department of Pulmonary and Critical Care Medicine, Shenzhen University of Advanced Technology General Hospital, Shenzhen, China.
ORCID-Profile: Ming Wu
Förderung
- Sanming Project of Medicine in Shenzhen
- Sanming Project of Medicine in Shenzhen, Guangming
Zitieren
APA
Yu, B., Li, D., Luan, Y., Rajagopalan, R., Guan, Y., Xiang, Y., Song, L., Fang, Z., Yao, Y., & Wu, M. (2026). De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2852-9288
Vancouver
Yu B, Li D, Luan Y, Rajagopalan R, Guan Y, Xiang Y, et al. De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2852-9288
BibTeX
@article{Yu2026,
author = {Yu, Bo and Li, Dazheng and Luan, Yingyi and Rajagopalan, Rajaganesh and Guan, Yuhong and Xiang, Yu and Song, Lei and Fang, Zhiye and Yao, Yongming and Wu, Ming},
title = {De Ritis Ratio and Heparin Therapy in Sepsis-Associated Liver Injury: A Multicenter Cohort Study},
journal = {Thrombosis and Haemostasis},
year = {2026},
doi = {10.1055/a-2852-9288}
}
EUVIMED